Abbott

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Abbott 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ABT

Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. 

CEO
Robert B. Ford
CEORobert B. Ford
Employees
115,000
Employees115,000
Headquarters
Abbott Park, Illinois
HeadquartersAbbott Park, Illinois
Founded
1888
Founded1888
Employees
115,000
Employees115,000

ABT Key Statistics

Market cap
191.93B
Market cap191.93B
Price-Earnings ratio
34.91
Price-Earnings ratio34.91
Dividend yield
2.26%
Dividend yield2.26%
Average volume
11.08M
Average volume11.08M
High today
$106.28
High today$106.28
Low today
$102.89
Low today$102.89
Open price
$104.42
Open price$104.42
Volume
9.61M
Volume9.61M
52 Week high
$137.49
52 Week high$137.49
52 Week low
$81.97
52 Week low$81.97

Stock Snapshot

Abbott(ABT) stock is priced at $106.04, giving the company a market capitalization of 191.93B. It carries a P/E multiple of 34.91 and pays a dividend yield of 2.26%.

As of 2026-08-01, Abbott(ABT) stock has fluctuated between $102.89 and $106.28. The current price stands at $106.04, placing the stock +3.1% above today's low and -0.2% off the high.

Abbott(ABT) shares are trading with a volume of 9.61M, against a daily average of 11.08M.

In the last year, Abbott(ABT) shares hit a 52-week high of $137.49 and a 52-week low of $81.97.

In the last year, Abbott(ABT) shares hit a 52-week high of $137.49 and a 52-week low of $81.97.

ABT News

The Motley Fool 13h
Abbott Laboratories vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?

Choosing between Abbott Laboratories (ABT +0.42%) and Johnson & Johnson (JNJ +0.65%) involves weighing steady growth against massive scale. Both healthcare gian...

Abbott Laboratories vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?
Simply Wall St 18h
Abbott Stock And 2 Dividend Compounders Built For Sticky Inflation

Stubborn inflation, louder Fed talk about interest rate hikes and higher energy costs linked to new geopolitical risks are pushing investors to rethink how they...

Abbott Stock And 2 Dividend Compounders Built For Sticky Inflation
Simply Wall St 2d
Why Abbott Is Up 7.4% After Mixed Q2 Results And Expanded Heart Device, Diagnostics Push

Abbott Laboratories recently reported second-quarter 2026 results showing sales rising to US$12,593 million from US$11,142 million a year earlier, while net inc...

Why Abbott Is Up 7.4% After Mixed Q2 Results And Expanded Heart Device, Diagnostics Push

Analyst ratings

78%

of 27 ratings
Buy
77.8%
Hold
22.2%
Sell
0%

More ABT News

Simply Wall St 3d
Abbott Lands Exclusive Rights To FDA Approved SimpleScreen In The U.S.

FDA has approved Freenome's SimpleScreen blood-based colorectal cancer test for average-risk adults. Abbott Laboratories, NYSE:ABT, holds exclusive rights to c...

Abbott Lands Exclusive Rights To FDA Approved SimpleScreen In The U.S.
TipRanks 3d
Abbott Laboratories: Buy Rating Backed by Strengthening Nutrition Franchise and 2026 Growth Drivers

In a report released yesterday, Josh Jennings from TD Cowen maintained a Buy rating on Abbott Laboratories, with a price target of $115.00. Claim 55% Off TipRan...

Nasdaq 3d
These 3 Companies Reported Record Results and Raised Guidance

The 2026 Q2 earnings cycle continues to roll along, with the reporting docket remaining stacked in the coming days and weeks. The period has been another one of...

These 3 Companies Reported Record Results and Raised Guidance
TipRanks 5d
Freenome, Abbott announce FDA approval of SimpleScreen CRC

Freenome (FRNM) and Abbott (ABT) announced that the FDA has approved SimpleScreen CRC, a new blood-based screening option for colorectal cancer in adults 45 and...

TipRanks 7d
Schwab US Dividend Equity ETF Sees Strong Inflows

Schwab US Dividend Equity ETF ( $SCHD ) has risen by 1.65% in the past week. It has experienced a 5-day net inflow of $682.61 million. This is due, in part, to...

Simply Wall St 7d
Abbott Laboratories Could Be 14% Undervalued On Mixed Earnings And Growth Focus

Abbott Laboratories (ABT) is back on investors’ radar after second quarter 2026 earnings showed higher year over year sales alongside lower net income and earni...

Abbott Laboratories Could Be 14% Undervalued On Mixed Earnings And Growth Focus

People also own

Based on the portfolios of people who own ABT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.